Curi RMB Capital LLC increased its stake in Morgan Stanley (NYSE:MS – Free Report) by 4.2% during the fourth quarter, HoldingsChannel reports. The firm owned 180,333 shares of the financial services provider’s stock after acquiring an additional 7,289 shares during the period. Curi RMB Capital LLC’s holdings in Morgan Stanley were worth $22,671,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. Peoples Bank KS bought a new stake in shares of Morgan Stanley in the fourth quarter valued at approximately $25,000. IAG Wealth Partners LLC bought a new position in shares of Morgan Stanley in the fourth quarter valued at approximately $28,000. Curio Wealth LLC bought a new position in Morgan Stanley in the 4th quarter valued at $31,000. Crowley Wealth Management Inc. bought a new stake in shares of Morgan Stanley during the fourth quarter valued at approximately $34,000. Finally, Stonebridge Financial Group LLC bought a new stake in Morgan Stanley during the 4th quarter worth about $35,000. Institutional investors and hedge funds own 84.19% of the company’s stock.
Morgan Stanley Price Performance
MS opened at $109.06 on Friday. The stock has a market cap of $175.89 billion, a P/E ratio of 13.74, a PEG ratio of 1.18 and a beta of 1.30. Morgan Stanley has a 52-week low of $90.36 and a 52-week high of $142.03. The business has a fifty day moving average of $119.53 and a 200 day moving average of $124.31. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 3.14.
Morgan Stanley Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Wednesday, April 30th will be given a $0.925 dividend. This represents a $3.70 dividend on an annualized basis and a dividend yield of 3.39%. The ex-dividend date is Wednesday, April 30th. Morgan Stanley’s dividend payout ratio (DPR) is presently 43.43%.
Insider Transactions at Morgan Stanley
In other Morgan Stanley news, CFO Raja Akram sold 17,500 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $136.01, for a total transaction of $2,380,175.00. Following the sale, the chief financial officer now owns 81,440 shares of the company’s stock, valued at approximately $11,076,654.40. This trade represents a 17.69 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Eric F. Grossman sold 13,097 shares of the firm’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $136.20, for a total value of $1,783,811.40. Following the completion of the sale, the insider now directly owns 197,444 shares of the company’s stock, valued at approximately $26,891,872.80. This trade represents a 6.22 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 40,665 shares of company stock valued at $5,288,079 over the last ninety days. Insiders own 0.24% of the company’s stock.
Analysts Set New Price Targets
MS has been the topic of several recent analyst reports. The Goldman Sachs Group reduced their target price on Morgan Stanley from $144.00 to $126.00 and set a “neutral” rating on the stock in a report on Wednesday, March 19th. Bank of America decreased their price objective on shares of Morgan Stanley from $150.00 to $144.00 and set a “buy” rating for the company in a research report on Wednesday, April 2nd. JMP Securities restated a “market perform” rating on shares of Morgan Stanley in a research note on Monday, April 14th. UBS Group lifted their target price on Morgan Stanley from $130.00 to $140.00 and gave the stock a “neutral” rating in a report on Tuesday, January 21st. Finally, Evercore ISI lowered their price objective on Morgan Stanley from $150.00 to $138.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 1st. Twelve equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $130.50.
Check Out Our Latest Analysis on Morgan Stanley
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Featured Stories
- Five stocks we like better than Morgan Stanley
- What Are Earnings Reports?
- MarketBeat Week in Review – 04/14 – 04/18
- Where to Find Earnings Call Transcripts
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- How to Use High Beta Stocks to Maximize Your Investing Profits
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.